The store will not work correctly when cookies are disabled.
4-(9H-purin-2-ylamino)-2,6-difluorophenol
ID: ALA4878386
PubChem CID: 164627508
Max Phase: Preclinical
Molecular Formula: C11H7F2N5O
Molecular Weight: 263.21
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Oc1c(F)cc(Nc2ncc3nc[nH]c3n2)cc1F
Standard InChI: InChI=1S/C11H7F2N5O/c12-6-1-5(2-7(13)9(6)19)17-11-14-3-8-10(18-11)16-4-15-8/h1-4,19H,(H2,14,15,16,17,18)
Standard InChI Key: NESFHNRJRFLAMW-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
12.3958 -4.3143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3947 -5.1411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1091 -5.5538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8251 -5.1406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8223 -4.3106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1073 -3.9017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1048 -3.0771 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.6816 -3.9021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6803 -5.5528 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.5399 -5.5518 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2533 -5.1384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9646 -5.5500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9570 -3.9009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2470 -4.3160 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6735 -4.3056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6805 -5.1334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4782 -5.4035 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9509 -4.7089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4587 -4.0433 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
1 8 1 0
2 9 1 0
4 10 1 0
10 11 1 0
11 12 2 0
12 16 1 0
15 13 1 0
13 14 2 0
14 11 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 19 2 0
19 15 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 263.21 | Molecular Weight (Monoisotopic): 263.0619 | AlogP: 2.08 | #Rotatable Bonds: 2 |
Polar Surface Area: 86.72 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.28 | CX Basic pKa: 2.01 | CX LogP: 1.80 | CX LogD: 1.75 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.62 | Np Likeness Score: -0.92 |
References
1. Casalvieri KA, Matheson CJ, Warfield BM, Backos DS, Reigan P.. (2021) N-Substituted pyrrolopyrimidines and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors., 41 [PMID:34034149] [10.1016/j.bmc.2021.116220] |